The corporate money behind psychedelic drug legalization
In April, President Trump, with psychedelic advocates HHS Secretary Robert Kennedy, Jr. and podcaster Joe Rogan at his side, signed the “Accelerating Medical Treatments for Serious Mental Illness” executive order, which dramatically decreases some drug approval times. FDA Commissioner Makary promptly issued priority review vouchers to companies that make psilocybin and the Ecstasy chemical cousin methylone.
Many public health professionals are surprised at how fast the move to legalize Schedule 1 …
The corporate money behind psychedelic drug legalization















